Diabetes Testing Centers™
Chronic Risk
Pre-Screening &
Assessments
Screen. Test. Treat.
TriageIQ™ | Multi-Domain Pre-Screener for Adults
Diabetes Testing Centers™
Chronic Risk
Pre-Screening &
Assessments
Screen. Test. Treat.
DTC helps clinics launch turnkey chronic disease detection programs using rapid multi-domain pre-screening, non-invasive assessments, and billable diagnostics.
Diabetes Testing Centers™ (DTC) has evolved beyond diabetes-related damage detection into a broader chronic-risk platform for modern adult healthcare. Built for primary care, DTC combines proprietary multi-domain pre-screening and helps providers uncover hidden risk signals earlier, strengthen documentation for medically necessary follow-up, and move patients toward timely, appropriate care before silent risks become serious complications.
Find Hidden Risk Signals
DTC was founded by former family practice owners who saw firsthand how often chronic risks are missed and patients had already begun suffering from preventable damage. That experience, combined with enterprise healthcare leadership in diagnostics and diabetes, shaped DTC’s development of scalable, non-invasive, billable point-of-care programs. Today, with access to a national network of more than 20,000 independent practices, DTC helps providers use TriageIQ™ as the intake-level pre-screener, then determine which focused screeners, assessments, or non-invasive diagnostics may be appropriate during the same visit.
Most chronic diseases do not begin with a diagnosis. They often begin years earlier with subtle changes in how a patient feels, functions, or moves — changes that may not appear in labs and may never become documented concerns. Patients often notice these changes but explain them away as aging, stress, fatigue, or “just getting older.” They may not schedule a visit, mention them during an existing one, or follow up until the symptoms become impossible to ignore. By then, the underlying disease process may have been active for years.
This is the gap structured chronic risk detection is designed to close. Not by adding complexity to the clinical visit, but by creating a systematic mechanism that surfaces what patients are already experiencing at the moment they are already present in the care setting. No additional appointment. No separate referral. No waiting for the patient to decide their symptoms are worth reporting. Healthcare organizations that build detection into the front end of care stop relying on patient-initiated concern as the trigger for clinical action. They capture risk while the patient is in the room, document it while medical necessity is present, and create a pathway forward before the window for early intervention closes. The visit does not change. The clinical intelligence it produces does.
Find Signals Sooner
The earliest signals emerge in the patient through symptoms, functional change, and subtle clinical patterns that precede what is formally documented in the chart. Adults represent the largest share of the U.S. population and carry the greatest overall burden of chronic disease risk. Adults ages 18–64 make up about 65.0% of this group, while adults 65+ make up about 19.3%. Together, adults 18+ represent about 84.3% of the population measured.
This matters because most chronic conditions become more common, measurable, and clinically actionable during adulthood. TriageIQ™ helps pre-screen adult patients for early risk signals across five core clinical domains, giving providers a broader intake picture before deciding whether focused single-domain screeners, assessments, or testing may be needed.
🔎 Population Health Risk. Establishes a baseline picture of patient risk before the encounter begins, helping providers understand how downstream signals may need to be interpreted.
❤️ Cardiometabolic Risk. Helps surface possible cardiometabolic signals related to diabetes complications, hypertension, vascular disease, obesity, and related chronic risk patterns.
🧠 Neurological Risk. Helps identify possible neurological signals that may warrant closer review, including cognitive, neuropathic, balance, or fall-risk concerns.
🧩 Behavioral Risk. Helps surface possible behavioral health signals that may affect chronic disease outcomes, including mood, sleep, stress, and emotional burden.
⚡ Pain & Function Risk. Helps identify pain, mobility, function, and lower-extremity concerns that may warrant focused assessment or further clinical review.
TriageIQ™ is a proprietary 3-minute adult multi-domain pre-screener that helps identify potential risk signals across five clinical domains and supports provider review for medically necessary follow-up.
Detecting these risks earlier helps protect patients before complications become life-altering. DTC delivers the clinical science behind Chronic Risk Assessments used by specialists nationwide, with flexible onboarding, seamless workflow integration, and the ability to begin generating recurring revenue in under 30 days.*
Identify Patient Signals
The clinical case for earlier testing is not theoretical — it is measurable. Chronic conditions including diabetes, hypertension, peripheral neuropathy, cognitive decline, and cardiovascular disease each follow a predictable trajectory: a long subclinical phase during which damage accumulates silently, followed by a clinical threshold at which intervention becomes reactive rather than preventive. The difference in patient outcomes between detecting a condition during the subclinical phase versus after complications have emerged is significant. So is the difference in cost, complexity, and the range of treatment options still available.
Most primary care workflows are not structured to identify risk during that earlier window. Patients present with a chief complaint. Providers respond to what is reported. What is not reported — early neuropathic changes, subtle cognitive shifts, vascular risk signals, behavioral health burden, or functional decline — is rarely captured because the intake process was not designed to pre-screen across multiple domains. Focused screeners, assessments, or testing that could have redirected the clinical pathway may never be considered.
DTC exists to change that equation. The programs, diagnostics, and workflows DTC brings into a practice are designed specifically to test earlier, within the visits that are already occurring, for the conditions that produce the greatest long-term harm when missed. Earlier testing does not require a different patient. It requires a more structured point of entry into the care that practice is already delivering.
The providers who benefit most are not those adding complexity to their practice. They are those who recognize that the clinical value was already there — in their existing patient panel, at their existing visit frequency — and simply needed a more structured pathway to surface it.
CMS-Ready
Aligned with National Guidelines
National guidelines are clear. What is less clear in most busy practices is how to meet them consistently within existing visit structures without adding staff, extending appointment times, or relying entirely on provider recall.
Most guidelines are written by domain: neuropathy, cognition, depression, peripheral arterial disease, cardiovascular risk, diabetic retinopathy, fall risk, and other chronic conditions. But primary care doesn't happen one domain at a time. Patients arrive with overlapping risks, incomplete complaints, and silent conditions that may not be obvious during the visit.
That is where TriageIQ™ creates value. As a multi-domain pre-screener, TriageIQ™ helps identify potential risk signals across multiple clinical domains at intake. Those signals can help the provider determine whether a focused single-domain screener, assessment, diagnostic test, or care pathway may be clinically appropriate.
The Annual Wellness Visit creates a structured opportunity to address many of these risks simultaneously. DTC’s programs are built to support this process through TriageIQ™ pre-screening first, followed by focused cognitive, behavioral, balance and gait, neuropathy, peripheral arterial disease, cardiovascular/autonomic, and diabetic retinopathy pathways when clinically appropriate.
DPN warrants specific attention because fiber type determines clinical consequence. Small fiber signals may reflect early metabolic dysfunction before symptoms are reported. Large fiber involvement is associated with loss of protective sensation, increasing concern for falls, ulcers, and amputation risk.
Consolidate Patient Care
Start by improving intake with multi-domain pre-screening — then let the patient signals show where focused screeners, assessments, testing pathways, and clinical opportunities may already exist inside your practice.
Getting Started Is Simple:
Start with TriageIQ™ Pre-Screening at Intake
Use TriageIQ™ as the front-door multi-domain pre-screener for adult patients to identify potential risk signals quickly and consistently at the beginning of care.
Identify the Risk Signals Showing Up in Your Clinic
As TriageIQ™ pre-screening results begin to surface patterns, your clinic can see which chronic disease domains appear most often and where focused single-domain screeners, assessments, or in-house testing may be most appropriate.
Address the Highest-Value Assessments in a 30–60–90 Day Rollout
TriageIQ™ begins creating value at intake immediately. Some patients may warrant focused single-domain screeners, assessments, or testing right away, while broader clinic-wide patterns typically become clear within the first 30 to 90 days of consistent use.
Schedule a Meeting to Build Your Rollout Plan. We help you determine the best starting point, review program options, and provide a financial pro forma based on your location, workflow, and payor mix so you can begin implementation with a clear path to deployment.
Start at Intake
"Book a 15‑minute walkthrough” to see how easily DTC programs integrate into your existing workflows.